APA (7th ed.) Citation

Adorini, L., Rigbolt, K., Feigh, M., Roth, J., & Erickson, M. (2024). Increased hepatoprotective effects of the novel farnesoid X receptor agonist INT-787 versus obeticholic acid in a mouse model of nonalcoholic steatohepatitis. PLoS ONE, 19(4), 1. https://doi.org/10.1371/journal.pone.0300809

Chicago Style (17th ed.) Citation

Adorini, Luciano, Kristoffer Rigbolt, Michael Feigh, Jonathan Roth, and Mary Erickson. "Increased Hepatoprotective Effects of the Novel Farnesoid X Receptor Agonist INT-787 Versus Obeticholic Acid in a Mouse Model of Nonalcoholic Steatohepatitis." PLoS ONE 19, no. 4 (2024): 1. https://doi.org/10.1371/journal.pone.0300809.

MLA (9th ed.) Citation

Adorini, Luciano, et al. "Increased Hepatoprotective Effects of the Novel Farnesoid X Receptor Agonist INT-787 Versus Obeticholic Acid in a Mouse Model of Nonalcoholic Steatohepatitis." PLoS ONE, vol. 19, no. 4, 2024, p. 1, https://doi.org/10.1371/journal.pone.0300809.